Abstract. Malaria control programs in endemic countries increasingly rely on early case detection and treatment at village level. The rapid diagnostic tests (RDTs) and accompanying drugs on which the success of these programs depends deteriorate to varying degrees at high temperatures. To assess the ability of health systems to maintain RDTs within manufacturers' specifications, we monitored temperatures in the delivery chain from manufacturer through to the village health worker in Cambodia and the Philippines. In both countries, storage temperatures regularly exceeded those recommended for most RDTs intended for field use, whereas temperatures during transport greatly exceeded the lower and upper limits. These results emphasize the need for good logistical planning during the introduction of point-of-care tests in tropical countries and the importance of considering the stability of diagnostic tests during procurement.
INTRODUCTION
The storage and use of malaria rapid diagnostic tests (RDTs) in remote areas presents a new challenge to many health systems. These devices, with limited shelf life and subject to degradation by the environment, are increasingly being deployed to remote and poorly resourced areas where users have limited supervision. In these settings, health personnel will rely on the RDTs to make potentially life-saving treatment decisions.
Exposure to high temperatures has the potential to degrade RDTs. Most manufacturers recommend storage between 4°C to 30°C, and shelf life is based on this assumption, but refrigeration and air-conditioning is commonly unavailable in malaria endemic areas where RDTs are intended for use. To document the conditions to which malaria RDTs are likely to be subjected in operational use, we monitored the temperatures during storage and routine transport in two countries where they are currently widely used: Cambodia and the Philippines. Drugs, including artemisinin-combination therapy (ACT), are transported and stored under similar conditions, and appreciating the environment to which RDTs and ACT are subject during routine use has important implications for the design of early case detection and treatment programs.
MATERIALS AND METHODS
Temperature monitoring. All temperatures were recorded using electronic temperature monitors (Smart Button Temperature Logger; ACR Systems, Surrey, Canada; range −10°C to +85°C, accuracy ±0.5°C) stored with the RDTs and programmed to record every 20 or 30 minutes during intercountry and in-country transport and every hour during longterm storage. Whenever the RDTs were moved, the date and information on the type of transport (aircraft, car, boat, foot) were recorded. Monitors in storage facilities were replaced every 10 weeks. Stored data was downloaded from the monitors, and daily and monthly temperature averages were calculated using Microsoft Excel. Inter-country shipment. Manufacturers of malaria RDTs agreed to include a temperature monitor with the RDTs before sending the consignments to the World Health Organization in the Philippines. Temperatures were monitored every hour during nine shipments.
RESULTS

Storage and transport in Cambodia.
Temperatures recorded in the CMS, Phnom Penh, ranged from 18°C to 30°C (mean, 24.2°C). At the provincial locations, temperature ranged from 15°C to 42.5°C. The mean annual storage temperature was 23.8°C and 29.3°C at Ankor Ban and Sampove Loun, respectively. Temperatures were more than 30°C for 39% of the recording period at Ankor Ban and 14% at Sampove Loun (Table 1 ) and were particularly high at Ankor Ban Health Center, where temperatures between 35°C and 40°C were recorded every month ( Figure 1 ).
The transport time from CMS to Ankor Ban Health Center through Sampov Loun was approximately 4 days. During transport, temperatures ranged from 22.5°C to 38.5°C (mean, 29.5°C). Temperature was more than 30°C for 37 hours, which was more than one third of this period (Table 1) .
Storage and transport temperatures the Philippines. The temperatures in the central storeroom at DoH in Manila ranged from 26°C to 34.5°C (mean, 29.4°C; Table 2 ). Temperatures were above the recommended 30°C for almost 30% of the monitoring period (Figure 2 ). In the six villages, temperatures ranged from 19°C to 38.5°C. The mean temperature in the six sites was similar, ranging from 26°C to 28°C. Temperatures more than 30°C were recorded in all locations for a mean 12% of the recording period, but they rarely exceeded 35°C ( Table 2 respectively. The mean temperature during transport was 30°C and 29.3°C, respectively, with a maximum of 49.5°C recorded when the transport vehicle was parked in the shade. During the first distribution round, the RDTs were exposed to temperatures more than 30°C for 114 cumulative hours (> 4 days). In the second round, the temperature was above the recommended range for 127 cumulative hours (∼5 days; Figure 3 ).
Temperatures during inter-country shipment. The recorded temperatures exceeded 30°C during all the shipments, before or after air shipment or both. In most cases, this was transient, and temperatures rarely surpassed 35°C. In-flight temperatures remained less than 30°C. One consignment of RDTs was frozen during shipment and stored at the airport of arrival in a freezer facility at an average of −3°C (minimum, −5°C), although no markings or documentation requested frozen storage.
DISCUSSION
The malaria rapid diagnostic tests monitored in this study were frequently exposed to conditions outside the 4-30°C limits recommended by most manufacturers. Excessive temperatures were documented in all storage facilities except the Development of a "cool chain" for RDTs is therefore essential. 10, 11 Most health services have experience with shortterm requirements for cold chains in remote areas for vaccines. However, while malaria RDTs do not require such stringent temperature control, the requirement to maintain control for prolonged periods at the most peripheral levels will be new to many health services. Temperature control of central storage facilities should be a basic requirement if storage is prolonged. 12 In remote health facilities, simple and inexpensive evaporative cooling boxes may offer a solution to the problem of high temperatures during long-term storage, and thatch roofs are likely to be cooler than iron roofs. Recent unpublished trials in Cambodia with evaporative cooling boxes designed for RDT storage indicate that storage temperatures can be reduced considerably (National Malaria Center, Cambodia). The use of cheap temperature monitors, such as vaccine vial monitors (VVMs), to indicate if the product is damaged, should also be studied. 13 However, the effect of cumulative high temperatures on the shelf life of different RDT products needs to be studied to determine the specifications of the appropriate VVMs.
Simple measures during transport from manufacturer and within countries can help avoid exposure of RDTs to high temperatures. These include notifying the shipper/air carrier of storage requirements, notification of arrival, avoid leaving RDTs inside a vehicle in the sun or on an airport tarmac, and transporting the RDTs in vehicles with air-conditioning whenever possible. Transport of RDTs in insulated containers could further reduce large temperature fluctuations. Clear temperature specifications should be displayed on packaging; FIGURE 2. Monthly average, maximum, and minimum temperature in a remote health facility (Tagusao) and in the Department of Health, Manila, the Philippines. the frozen storage recorded in one shipment in this study could destroy some RDTs. Maintaining transport and storage of RDTs less than 30°C may be impossible in many malaria endemic countries, as shown in this study. Therefore, besides ensuring and monitoring proper transport and storage, it is clearly important to regularly test the sensitivity of the RDTs. Test wells containing recombinant parasite antigen are commercially available and under development, 14 whereas comparison with microscopy in representative sentinel sites may be a useful alternative.
The temperatures documented in Cambodia and in the Philippines have implications beyond the performance of malaria RDTs. Antimalarials and other essential drugs are commonly stored under the same conditions, thus exposing them to temperatures above the recommended maximum storage (e.g., 25°C for artemether-lumefantrine), with the likelihood of reduced drug efficacy. 15 Rapid tests for detection of other diseases are sometimes used and transported in similar conditions, with little quality monitoring, and the implications of low sensitivity of tests for HIV and viral hepatitis to blood banking and case management are clear. Careful planning of distribution and storage, purchasing policies that take product stability and intended conditions of use into account, and consideration of staggered procurement to minimize postpurchase storage time should be part of a national policy for malaria and for other diseases requiring diagnosis and treatment at the periphery of the health service.
